Who Buys Verapamil from India — 225 Importers Behind a $110.6M Market
India's verapamil import market is served by 225 active buyers who collectively imported $110.6M across 1,236 shipments. LIFESCIENCE LOGISTICS. (UNITED STATES) leads with a 57.2% market share, followed by EVERSANA LIFE SCIENCE SERVICES and CSP VIATRIS SANTE AT CSP-LAB. The top 5 buyers together control 82.0% of total import value, reflecting a concentrated buyer landscape.
Top Verapamil Importers — Ranked by Import Value
LIFESCIENCE LOGISTICS. (UNITED STATES) is the leading verapamil importer from India, holding a 57.2% share of the $110.6M market across 1,236 shipments from 225 buyers. The top 5 buyers — LIFESCIENCE LOGISTICS. (UNITED STATES), EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), CSP VIATRIS SANTE AT CSP-LAB (FRANCE), GLENMARK PHARMACEUTICALS INC., USA (UNITED STATES), CSP VIATRIS SANTE AT CSP- LAB, (FRANCE) — collectively control 82.0% of total import value.
Top Verapamil Buyers & Importers
Ranked by import value · 225 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | LIFESCIENCE LOGISTICS.UNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYDPHARMACEUTICAL PRODUCTS VEGAMINVEGAMIN | $63.3M | 5 | 57.2% |
| 2 | EVERSANA LIFE SCIENCE SERVICESUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $9.9M | 5 | 8.9% |
| 3 | CSP VIATRIS SANTE AT CSP-LABFRANCE VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLVERAPAMIL MYLAN PHARMA L.P. 240 MG 30BL | $7.2M | 5 | 6.5% |
| 4 | GLENMARK PHARMACEUTICALS INC., USAUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $5.1M | 5 | 4.7% |
| 5 | CSP VIATRIS SANTE AT CSP- LAB,FRANCE VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLVERAPAMIL MYLAN PHARMA L.P. 240 MG 30BL | $5.1M | 5 | 4.6% |
| 6 | LIFESCIENCE LOGISTICSUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYDPHARMACEUTICAL PRODUCTS VEGAMINVEGAMIN | $4.0M | 5 | 3.7% |
| 7 | GLENMARK PHARMACEUTICALS INC USAUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $3.0M | 5 | 2.7% |
| 8 | CARDINAL 3PLUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $1.3M | 5 | 1.1% |
| 9 | MYLAN PHARMACEUTICALS INCUNITED STATES VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLPHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $1.1M | 5 | 1.0% |
| 10 | BAXTER HEALTHCARE CORPORATIONUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $861.7K | 5 | 0.8% |
| 11 | LIFESTAR PHARMA LLCUNITED STATES PHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $770.7K | 5 | 0.7% |
| 12 | CSP VIATRIS SANTE AT CSP- LABO,FRANCE VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLVERAPAMIL MYLAN PHARMA L.P. 240 MG 30BL | $633.1K | 5 | 0.6% |
| 13 | CSP VIATRIS SANTE AT CSP LABFRANCE VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLVERAPAMIL MYLAN PHARMA L.P. 240 MG 30BL | $533.7K | 5 | 0.5% |
| 14 | MYLAN PHARMACEUTICALS INC.,UNITED STATES VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLPHARMACEUTICALS MEDICINES: VERAPAMIL HYD | $528.2K | 5 | 0.5% |
| 15 | M/S. CSP MYLAN SAS AT CSP LABO 274FRANCE VERAPAMIL MYLAN PHARMA L P 240 MG 90BL TAB PACKS 13439HARMLESS MEDICINES, VERAPAMIL MYLAN PHARMA L.P. 240 MG 30BLVERAPAMIL MYLAN PHARMA L.P. 240 MG 30BL | $517.1K | 5 | 0.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Verapamil — and from which countries?
Flow of Verapamil exports from India: each country's share and the named importers behind the numbers
Verapamil — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $93.9M through 343 shipments. This represents a market share of 84.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• LIFESCIENCE LOGISTICS. - $63.3M (67.4% of country's total business)
• EVERSANA LIFE SCIENCE SERVICES - $9.9M (10.5% of country's total business)
• GLENMARK PHARMACEUTICALS INC., USA - $5.1M (5.5% of country's total business)
• LIFESCIENCE LOGISTICS - $4.0M (4.3% of country's total business)
• GLENMARK PHARMACEUTICALS INC USA - $3.0M (3.2% of country's total business)
• Rest of United States's importers - $8.5M (9.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $273.8K, indicating premium pricing strategy compared to the market average of $89.5K.
United States is a key market for Verapamil imports, representing 84.9% of total trade value.
2France
France emerges as the second largest importing country, achieving a total trade value of $15.4M through 41 shipments. This represents a market share of 14.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• CSP VIATRIS SANTE AT CSP-LAB - $7.2M (46.4% of country's total business)
• CSP VIATRIS SANTE AT CSP- LAB, - $5.1M (33.3% of country's total business)
• CSP VIATRIS SANTE AT CSP- LABO, - $633.1K (4.1% of country's total business)
• CSP VIATRIS SANTE AT CSP LAB - $533.7K (3.5% of country's total business)
• M/S. CSP MYLAN SAS AT CSP LABO 274 - $517.1K (3.3% of country's total business)
• Rest of France's importers - $1.5M (9.4% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $376.6K, indicating premium pricing strategy compared to the market average of $89.5K.
France is a key market for Verapamil imports, representing 14.0% of total trade value.
3Mexico
Mexico emerges as the third largest importing country, achieving a total trade value of $251.0K through 0 shipments. This represents a market share of 0.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Mexico demonstrates strong market positioning with an average shipment value of $251.0K, indicating premium pricing strategy compared to the market average of $89.5K.
Mexico is a key market for Verapamil imports, representing 0.2% of total trade value.
4Netherlands
Netherlands emerges as the fourth largest importing country, achieving a total trade value of $212.5K through 0 shipments. This represents a market share of 0.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $212.5K, indicating premium pricing strategy compared to the market average of $89.5K.
Netherlands is a key market for Verapamil imports, representing 0.2% of total trade value.
5Panama
Panama emerges as the fifth largest importing country, achieving a total trade value of $133.8K through 0 shipments. This represents a market share of 0.1% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Panama demonstrates strong market positioning with an average shipment value of $133.8K, indicating premium pricing strategy compared to the market average of $89.5K.
Panama is a key market for Verapamil imports, representing 0.1% of total trade value.
Buyer Segment Analysis
TransData Nexus Verapamil buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Verapamil imported from India encompasses several key segments:
1. Distributors: Entities like LIFESCIENCE LOGISTICS and EVERSANA LIFE SCIENCE SERVICES in the United States fall into this category. They purchase large quantities to supply various healthcare providers, ensuring consistent availability. Their order patterns are characterized by bulk purchases and regular restocking to meet ongoing demand.
2. Contract Manufacturers: Companies such as GLENMARK PHARMACEUTICALS INC., USA, and MYLAN PHARMACEUTICALS INC operate in this segment. They procure Verapamil as an active pharmaceutical ingredient (API) for formulation into finished products. Their purchasing behavior is aligned with production schedules, leading to periodic, sizable orders.
3. Hospital Groups and Healthcare Providers: Organizations like CSP VIATRIS SANTE AT CSP-LAB in France represent this segment. They import Verapamil directly to meet the therapeutic needs of their patients. Their procurement is driven by patient demand and treatment protocols, resulting in consistent, moderate-sized orders.
4. Re-exporters: Entities such as CARDINAL 3PL in the United States may function as re-exporters, importing Verapamil for distribution to other markets. Their buying patterns are influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.
Understanding these segments and their purchasing behaviors is crucial for suppliers aiming to tailor their strategies to meet the specific needs of each buyer type.
Country-Specific Import Regulations
TransData Nexus Verapamil buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Verapamil from India, the import regulations are as follows:
1. United States:
2. France:
3. Mexico:
4. Netherlands:
5. Panama:
Importers are advised to consult the respective regulatory authorities and tariff schedules for the most current and detailed information.
Demand Drivers & Market Opportunity
TransData Nexus Verapamil buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Verapamil in importing countries is driven by several factors:
1. Disease Prevalence: Verapamil is primarily used to treat cardiovascular conditions such as hypertension and arrhythmias. The global rise in cardiovascular diseases, attributed to factors like aging populations and lifestyle changes, has increased the demand for effective treatments like Verapamil.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to provide broader access to essential medicines. For instance, the World Health Organization's push for universal health coverage has led nations to include drugs like Verapamil in their national formularies, ensuring wider availability.
3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Verapamil's inclusion in the WHO Essential Medicines List underscores its importance in basic healthcare. This inclusion often leads to bulk procurement through international tenders by organizations such as UNICEF and the Global Fund, creating significant market opportunities for suppliers.
With 225 buyers across 69 countries, the global reach and consistent demand for Verapamil present substantial opportunities for exporters, especially those from India, to cater to diverse markets and contribute to global health initiatives.
Common Questions — Verapamil Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest verapamil buyer importing from India?
Based on import volume and value, LIFESCIENCE LOGISTICS. (UNITED STATES) leads with $63.3M in imports and a 57.2% market share — the highest of any single verapamil importer. EVERSANA LIFE SCIENCE SERVICES (UNITED STATES) and CSP VIATRIS SANTE AT CSP-LAB (FRANCE) are the next largest buyers.
QHow many companies buy verapamil from India?
There are 225 active verapamil buyers importing from India, with a combined market of $110.6M across 1,236 shipments to 69 countries. The top 5 buyers hold 82.0% of total import value, while the remaining 220 buyers handle the other 18.0%.
QWhich countries import the most verapamil from India?
The top importing countries for verapamil from India are United States (84.9%), France (14.0%), Mexico (0.2%), Netherlands (0.2%), Panama (0.1%). These markets represent the largest demand centres for Indian pharmaceutical exports of verapamil, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for verapamil from India?
The average import transaction value for verapamil from India is $89.5K, with an average unit price of $11.32 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Verapamil buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for Verapamil imported from India encompasses several key segments:
1. Distributors: Entities like LIFESCIENCE LOGISTICS and EVERSANA LIFE SCIENCE SERVICES in the United States fall into this category. They purchase large quantities to supply various healthcare providers, ensuring consistent availability. Their order patterns are characterized by bulk purchases and regular restocking to meet ongoing demand.
2. Contract Manufacturers: Companies such as GLENMARK PHARMACEUTICALS INC., USA, and MYLAN PHARMACEUTICALS INC operate in this segment. They procure Verapamil as an active pharmaceutical ingredient (API) for formulation into finished products. Their purchasing behavior is aligned with production schedules, leading to periodic, sizable orders.
3. Hospital Groups and Healthcare Providers: Organizations like CSP VIATRIS SANTE AT CSP-LAB in France represent this segment. They import Verapamil directly to meet the therapeutic needs of their patients. Their procurement is driven by patient demand and treatment protocols, resulting in consistent, moderate-sized orders.
4. Re-exporters: Entities such as CARDINAL 3PL in the United States may function as re-exporters, importing Verapamil for distribution to other markets. Their buying patterns are influenced by global demand fluctuations and trade agreements, leading to variable order sizes and frequencies.
Understanding these segments and their purchasing behaviors is crucial for suppliers aiming to tailor their strategies to meet the specific needs of each buyer type.
Country-Specific Import Regulations
TransData Nexus Verapamil buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Verapamil from India, the import regulations are as follows:
1. United States:
2. France:
3. Mexico:
4. Netherlands:
5. Panama:
Importers are advised to consult the respective regulatory authorities and tariff schedules for the most current and detailed information.
Demand Drivers & Market Opportunity
TransData Nexus Verapamil buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Verapamil in importing countries is driven by several factors:
1. Disease Prevalence: Verapamil is primarily used to treat cardiovascular conditions such as hypertension and arrhythmias. The global rise in cardiovascular diseases, attributed to factors like aging populations and lifestyle changes, has increased the demand for effective treatments like Verapamil.
2. Government Healthcare Programs and Universal Health Coverage Expansion: Many countries are expanding their healthcare programs to provide broader access to essential medicines. For instance, the World Health Organization's push for universal health coverage has led nations to include drugs like Verapamil in their national formularies, ensuring wider availability.
3. WHO Essential Medicines List Procurement and Tender-Based Purchasing: Verapamil's inclusion in the WHO Essential Medicines List underscores its importance in basic healthcare. This inclusion often leads to bulk procurement through international tenders by organizations such as UNICEF and the Global Fund, creating significant market opportunities for suppliers.
With 225 buyers across 69 countries, the global reach and consistent demand for Verapamil present substantial opportunities for exporters, especially those from India, to cater to diverse markets and contribute to global health initiatives.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 225 global importers of Verapamil identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,236 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 69 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,236 Verified Shipments
225 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists